IL2 and neoplasm: Importantly, the activating effects of FAP-IL-2v on effector cells by IL-2v has been shown to be translated into the considerably enhanced antitumor activity of these effector cells against tumor cells mediated by the therapeutic Ab [7], thus clearly showing advantageous therapeutic effects compared to the non-modified IL-2.